Imfinzi Combination Therapy

• Business
• Education
• Financial
• Healthcare
• Industrial
• Investment
• Management
• News
• Pharma & Biotech
• Science
• Technology
• United Kingdom

AstraZeneca’s Imfinzi Combination Therapy Shows Promise in Phase III Trial for Liver Cancer Treatment

(IN BRIEF) AstraZeneca has reported positive high-level results from the EMERALD-1 Phase III trial, demonstrating that its drug Imfinzi (durvalumab),…